Gilenya hit's 3000 RX in 6 weeks

Quote




No. Cover one of the largest cities in the US and there have been ZERO Rx filled.

No payors are paying for it and the reimbursement for the 6 hour first dose is less than $20.
 






























Anonymous said:
worst launch i have ever seen - huge demand for an oral and barely being used 3 months in - more layoffs at novartis are coming!
Click to expand...

4300 RX's half come from Biogen in just 3 months. Yes its slow to get them on but they will get on. Say good bye to killsabri and Avonex was losing share even before Gilenya.
 



Anonymous said:
4300 RX's half come from Biogen in just 3 months. Yes its slow to get them on but they will get on. Say good bye to killsabri and Avonex was losing share even before Gilenya.
Click to expand...

Take a common sense approach. The risk of PML using Tysabri has doubled since two year plus data has become available. Researchers have stated that a negative test to the JCV virus doesn't guarantee you won't get PML. Along comes an oral drug which eliminates the need for monthly infusions.

Now if you are a newly diagnosed MS patient or the ABCR drugs aren't cutting it for you anymore, what choice would you likely make?
 



Anonymous said:
Take a common sense approach. The risk of PML using Tysabri has doubled since two year plus data has become available. Researchers have stated that a negative test to the JCV virus doesn't guarantee you won't get PML. Along comes an oral drug which eliminates the need for monthly infusions.

Now if you are a newly diagnosed MS patient or the ABCR drugs aren't cutting it for you anymore, what choice would you likely make?
Click to expand...


Well said but those money hungry docs will still use Tysabri.
 



Uh, if you are a newly diagnosed patient and told a/b/c/r no deaths in 20 years vs gilenya 2 deaths in 1700 patients in the trials and by the way pml and tysabri was only found out after the launch, which would you take?

Not so sure "money hungry docs" are pushing people to tysabri. See there is this thing called a lawsuit that doctors can get but pharmacy reps, not so much.
 



Anonymous said:
Uh, if you are a newly diagnosed patient and told a/b/c/r no deaths in 20 years vs gilenya 2 deaths in 1700 patients in the trials and by the way pml and tysabri was only found out after the launch, which would you take?
Click to expand...

The ONLY reason why PML was found out after the launch was because the launch was rushed ahead by one year. Otherwise there would have been 2 cases known before any approval by the FDA.
 



so tysabri's launch was rushed, that still doesnt change the fact that 2 people died out of 1700 with gilenya and no one has died with the injectables. gilenya will be the tysabri substitute, the med you use after failing the others.
 



gilenya may have the same risk as tysabri but may not be as effective. not a really good deal. only time will tell. doctors will naturally proceed slowly -which is the right course to take. patients demanding a pill will switch docs if necessary. after the first six months peak of "demanding" patients being satisfied, gilenya will have a very slow and steady uptake.
 



ALL of these drugs have risks and these patients are willing to take them. So until all of you at Biogen pull your heads out and quit drinking the Kool Aid, ANY new drug is going to be a threat......period. Be a good rep and be prepared and those are the ones who will be ready. These new drugs will be used so get used to it
 







Write your reply...
Top Bottom
Back
Quote